Andrew Berens
Stock Analyst at Leerink Partners
(4.86)
# 349
Out of 4,683 analysts
529
Total ratings
48.4%
Success rate
24.5%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPX Compass Therapeutics | Maintained: Buy | $7 | $2.43 | +188.07% | 26 | Aug 7, 2026 | |
| EXEL Exelixis | Downgraded: Hold | $48 → $52 | $56.10 | -7.31% | 13 | Aug 6, 2026 | |
| INCY Incyte | Maintained: Buy | $103 → $155 | $128.12 | +20.98% | 62 | Aug 3, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $33.99 | - | 52 | Jul 7, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $40 | $39.26 | +1.88% | 1 | Jul 6, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | n/a | $7.73 | - | 28 | Jun 2, 2026 | |
| STRO Sutro Biopharma | Rated: Buy | $38 → $43 | $21.43 | +100.65% | 2 | May 15, 2026 | |
| TNGX Tango Therapeutics | Rated: Buy | $10 → $55 | $25.47 | +115.94% | 26 | May 15, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 → $33 | $28.75 | +14.78% | 14 | May 15, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | $46 → $51 | $30.39 | +67.82% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $15.06 | +52.72% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $9.26 | +342.76% | 3 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $4.55 | +75.82% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $40 | $29.31 | +36.50% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $97 | $95.08 | +2.02% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $36.72 | +36.17% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $5.15 | +191.26% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $41.58 | -20.63% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.85 | - | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $3.80 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $19.46 | n/a | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $2.92 | n/a | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $375.80 | n/a | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $9.32 | n/a | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $3.89 | n/a | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 | $9.84 | n/a | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $170.92 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $74.32 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 → $25 | $4.24 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $15 | $14.38 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.75 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $9.16 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $111.87 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $8 | $10.77 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.92 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9065 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $48.99 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $148.09 | n/a | 3 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.15 | n/a | 2 | Dec 1, 2014 |
Compass Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $7
Current: $2.43
Upside: +188.07%
Exelixis
Aug 6, 2026
Downgraded: Hold
Price Target: $48 → $52
Current: $56.10
Upside: -7.31%
Incyte
Aug 3, 2026
Maintained: Buy
Price Target: $103 → $155
Current: $128.12
Upside: +20.98%
Agios Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: n/a
Current: $33.99
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $39.26
Upside: +1.88%
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.73
Upside: -
Sutro Biopharma
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $21.43
Upside: +100.65%
Tango Therapeutics
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $25.47
Upside: +115.94%
Immunome
May 15, 2026
Maintained: Buy
Price Target: $40 → $33
Current: $28.75
Upside: +14.78%
Damora Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $46 → $51
Current: $30.39
Upside: +67.82%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $15.06
Upside: +52.72%
Mar 6, 2026
Reiterated: Buy
Price Target: $41
Current: $9.26
Upside: +342.76%
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.55
Upside: +75.82%
Nov 19, 2025
Maintained: Buy
Price Target: $24 → $40
Current: $29.31
Upside: +36.50%
Nov 17, 2025
Maintained: Buy
Price Target: $70 → $97
Current: $95.08
Upside: +2.02%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $36.72
Upside: +36.17%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $5.15
Upside: +191.26%
Oct 21, 2025
Maintained: Hold
Price Target: $30 → $33
Current: $41.58
Upside: -20.63%
Sep 4, 2025
Maintained: Buy
Price Target: n/a
Current: $22.85
Upside: -
Aug 13, 2025
Maintained: Buy
Price Target: $33
Current: $3.80
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $19.46
Upside: n/a
Aug 11, 2025
Maintained: Hold
Price Target: $3
Current: $2.92
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $375.80
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: $9
Current: $9.32
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $3.89
Upside: n/a
Aug 5, 2025
Maintained: Buy
Price Target: $18.00
Current: $9.84
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: n/a
Current: $170.92
Upside: n/a
Dec 10, 2024
Maintained: Buy
Price Target: n/a
Current: $74.32
Upside: n/a
Feb 7, 2023
Maintained: Buy
Price Target: $67 → $25
Current: $4.24
Upside: n/a
Feb 7, 2023
Maintained: Hold
Price Target: $20 → $15
Current: $14.38
Upside: n/a
Mar 21, 2022
Maintained: Buy
Price Target: n/a
Current: $8.75
Upside: n/a
May 7, 2021
Maintained: Hold
Price Target: $10
Current: $9.16
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Maintained: Hold
Price Target: $23
Current: $111.87
Upside: n/a
Jul 14, 2017
Maintained: Hold
Price Target: $16 → $8
Current: $10.77
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $7.92
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.9065
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $48.99
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $148.09
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $14.15
Upside: n/a